phase 2
iiiii 2
randomized 2
study 2
compare 2
efficacy 2
safety 2
rigosertib 2
plus 2
gemcitabine 4
versus 2
alone 2
patients 2
previously 2
untreated 2
metastatic 2
pancreatic 2
cancer 2
